Charles River Laboratories International, Inc. (CRL)
USD 99.06
(-0.9%)
USD 99.06
(-0.9%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 4.12 Billion USD | 3.86% |
| 2022 | 3.97 Billion USD | 12.31% |
| 2021 | 3.54 Billion USD | 21.08% |
| 2020 | 2.92 Billion USD | 11.55% |
| 2019 | 2.62 Billion USD | 15.67% |
| 2018 | 2.26 Billion USD | 21.99% |
| 2017 | 1.85 Billion USD | 10.48% |
| 2016 | 1.68 Billion USD | 23.34% |
| 2015 | 1.36 Billion USD | 5.06% |
| 2014 | 1.29 Billion USD | 11.34% |
| 2013 | 1.16 Billion USD | 3.19% |
| 2012 | 1.12 Billion USD | -1.15% |
| 2011 | 1.14 Billion USD | 0.81% |
| 2010 | 1.13 Billion USD | -5.75% |
| 2009 | 1.2 Billion USD | -10.49% |
| 2008 | 1.34 Billion USD | 9.17% |
| 2007 | 1.23 Billion USD | 16.27% |
| 2006 | 1.05 Billion USD | -5.69% |
| 2005 | 1.12 Billion USD | 46.33% |
| 2004 | 766.91 Million USD | 24.96% |
| 2003 | 613.72 Million USD | 10.65% |
| 2002 | 554.62 Million USD | 19.11% |
| 2001 | 465.63 Million USD | 51.88% |
| 2000 | 306.58 Million USD | 39.82% |
| 1999 | 219.27 Million USD | 13.44% |
| 1998 | 193.3 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.02 Billion USD | 1.44% |
| 2024 Q1 | 1.01 Billion USD | -0.19% |
| 2023 Q4 | 1.01 Billion USD | -1.28% |
| 2023 Q3 | 1.02 Billion USD | -3.14% |
| 2023 Q2 | 1.05 Billion USD | 2.97% |
| 2023 FY | 4.12 Billion USD | 3.86% |
| 2023 Q1 | 1.02 Billion USD | -6.41% |
| 2022 Q1 | 913.92 Million USD | 0.98% |
| 2022 Q3 | 989.15 Million USD | 1.65% |
| 2022 Q4 | 1.09 Billion USD | 11.19% |
| 2022 FY | 3.97 Billion USD | 12.31% |
| 2022 Q2 | 973.13 Million USD | 6.48% |
| 2021 Q3 | 895.93 Million USD | -2.04% |
| 2021 Q1 | 824.56 Million USD | 4.24% |
| 2021 Q4 | 905.05 Million USD | 1.02% |
| 2021 FY | 3.54 Billion USD | 21.08% |
| 2021 Q2 | 914.6 Million USD | 10.92% |
| 2020 Q2 | 682.58 Million USD | -3.46% |
| 2020 FY | 2.92 Billion USD | 11.55% |
| 2020 Q4 | 790.99 Million USD | 6.42% |
| 2020 Q3 | 743.3 Million USD | 8.9% |
| 2020 Q1 | 707.05 Million USD | 2.3% |
| 2019 Q4 | 691.13 Million USD | 3.47% |
| 2019 Q1 | 604.56 Million USD | 0.51% |
| 2019 Q2 | 657.56 Million USD | 8.77% |
| 2019 Q3 | 667.95 Million USD | 1.58% |
| 2019 FY | 2.62 Billion USD | 15.67% |
| 2018 FY | 2.26 Billion USD | 21.99% |
| 2018 Q3 | 585.29 Million USD | -0.0% |
| 2018 Q4 | 601.53 Million USD | 2.77% |
| 2018 Q2 | 585.3 Million USD | 18.49% |
| 2018 Q1 | 493.97 Million USD | 3.24% |
| 2017 Q3 | 464.23 Million USD | -1.04% |
| 2017 Q2 | 469.12 Million USD | 5.24% |
| 2017 Q1 | 445.76 Million USD | -4.5% |
| 2017 Q4 | 478.47 Million USD | 3.07% |
| 2017 FY | 1.85 Billion USD | 10.48% |
| 2016 Q4 | 466.78 Million USD | 9.65% |
| 2016 Q1 | 354.86 Million USD | 0.29% |
| 2016 Q3 | 425.72 Million USD | -1.92% |
| 2016 Q2 | 434.05 Million USD | 22.31% |
| 2016 FY | 1.68 Billion USD | 23.34% |
| 2015 FY | 1.36 Billion USD | 5.06% |
| 2015 Q1 | 320.41 Million USD | -2.77% |
| 2015 Q2 | 339.57 Million USD | 5.98% |
| 2015 Q3 | 349.46 Million USD | 2.91% |
| 2015 Q4 | 353.85 Million USD | 1.25% |
| 2014 Q2 | 341.17 Million USD | 13.97% |
| 2014 Q4 | 329.54 Million USD | 0.6% |
| 2014 FY | 1.29 Billion USD | 11.34% |
| 2014 Q1 | 299.36 Million USD | 3.51% |
| 2014 Q3 | 327.56 Million USD | -3.99% |
| 2013 FY | 1.16 Billion USD | 3.19% |
| 2013 Q4 | 289.22 Million USD | -0.99% |
| 2013 Q3 | 292.12 Million USD | -0.27% |
| 2013 Q2 | 292.93 Million USD | 0.58% |
| 2013 Q1 | 291.23 Million USD | 3.96% |
| 2012 Q2 | 284.72 Million USD | -0.44% |
| 2012 FY | 1.12 Billion USD | -1.15% |
| 2012 Q3 | 278.68 Million USD | -2.12% |
| 2012 Q1 | 285.98 Million USD | -1.71% |
| 2012 Q4 | 280.14 Million USD | 0.52% |
| 2011 Q1 | 285.84 Million USD | 6.7% |
| 2011 Q2 | 288.26 Million USD | 0.85% |
| 2011 Q3 | 277.57 Million USD | -3.71% |
| 2011 Q4 | 290.96 Million USD | 4.82% |
| 2011 FY | 1.14 Billion USD | 0.81% |
| 2010 Q2 | 292.1 Million USD | -1.76% |
| 2010 FY | 1.13 Billion USD | -5.75% |
| 2010 Q1 | 297.34 Million USD | 0.66% |
| 2010 Q3 | 276.08 Million USD | -5.49% |
| 2010 Q4 | 267.88 Million USD | -2.97% |
| 2009 FY | 1.2 Billion USD | -10.49% |
| 2009 Q1 | 301.52 Million USD | -3.19% |
| 2009 Q2 | 308.15 Million USD | 2.2% |
| 2009 Q3 | 297.48 Million USD | -3.46% |
| 2009 Q4 | 295.38 Million USD | -0.71% |
| 2008 Q4 | 311.44 Million USD | -8.99% |
| 2008 FY | 1.34 Billion USD | 9.17% |
| 2008 Q3 | 342.22 Million USD | -2.81% |
| 2008 Q2 | 352.13 Million USD | 4.28% |
| 2008 Q1 | 337.68 Million USD | 6.18% |
| 2007 Q2 | 307.43 Million USD | 5.58% |
| 2007 FY | 1.23 Billion USD | 16.27% |
| 2007 Q1 | 291.19 Million USD | 7.17% |
| 2007 Q3 | 313.96 Million USD | 2.12% |
| 2007 Q4 | 318.02 Million USD | 1.29% |
| 2006 Q4 | 271.72 Million USD | 2.67% |
| 2006 Q1 | 283.76 Million USD | -2.54% |
| 2006 Q2 | 267.85 Million USD | -5.61% |
| 2006 FY | 1.05 Billion USD | -5.69% |
| 2006 Q3 | 264.66 Million USD | -1.19% |
| 2005 Q1 | 273.72 Million USD | 14.98% |
| 2005 Q2 | 283.41 Million USD | 3.54% |
| 2005 Q3 | 273.93 Million USD | -3.34% |
| 2005 Q4 | 291.15 Million USD | 6.28% |
| 2005 FY | 1.12 Billion USD | 46.33% |
| 2004 FY | 766.91 Million USD | 24.96% |
| 2004 Q1 | 172.63 Million USD | 10.64% |
| 2004 Q2 | 180.19 Million USD | 4.38% |
| 2004 Q3 | 176.02 Million USD | -2.31% |
| 2004 Q4 | 238.06 Million USD | 35.24% |
| 2003 FY | 613.72 Million USD | 10.65% |
| 2003 Q3 | 151.19 Million USD | -2.05% |
| 2003 Q4 | 156.04 Million USD | 3.21% |
| 2003 Q1 | 152.12 Million USD | 6.42% |
| 2003 Q2 | 154.36 Million USD | 1.47% |
| 2002 Q4 | 142.94 Million USD | 1.12% |
| 2002 Q3 | 141.36 Million USD | 3.56% |
| 2002 Q2 | 136.5 Million USD | 2.0% |
| 2002 Q1 | 133.82 Million USD | 6.13% |
| 2002 FY | 554.62 Million USD | 19.11% |
| 2001 Q1 | 99.03 Million USD | 9.05% |
| 2001 FY | 465.63 Million USD | 51.88% |
| 2001 Q4 | 126.09 Million USD | 1.95% |
| 2001 Q3 | 123.68 Million USD | 5.88% |
| 2001 Q2 | 116.82 Million USD | 17.96% |
| 2000 FY | 306.58 Million USD | 39.82% |
| 2000 Q4 | 90.81 Million USD | 25.48% |
| 2000 Q3 | 72.37 Million USD | -2.33% |
| 2000 Q1 | 69.3 Million USD | 0.0% |
| 2000 Q2 | 74.09 Million USD | 6.92% |
| 1999 FY | 219.27 Million USD | 13.44% |
| 1998 FY | 193.3 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Agilent Technologies, Inc. | 6.83 Billion USD | 39.567% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | 55.367% |
| Danaher Corporation | 23.89 Billion USD | 82.715% |
| Enzo Biochem, Inc. | 31.9 Million USD | -12842.016% |
| IQVIA Holdings Inc. | 14.98 Billion USD | 72.441% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | 66.046% |
| Mettler-Toledo International Inc. | 3.78 Billion USD | -9.004% |
| Qiagen N.V. | 1.96 Billion USD | -110.115% |
| Revvity, Inc. | 2.75 Billion USD | -50.129% |
| Thermo Fisher Scientific Inc. | 42.85 Billion USD | 90.365% |
| Waters Corporation | 2.95 Billion USD | -39.676% |